These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1669525)

  • 1. Trials of hypertension prevention. Phase I design.
    Satterfield S; Cutler JA; Langford HG; Applegate WB; Borhani NO; Brittain E; Cohen JD; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1991 Aug; 1(5):455-71. PubMed ID: 1669525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
    JAMA; 1992 Mar; 267(9):1213-20. PubMed ID: 1586398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.
    Whelton PK; Kumanyika SK; Cook NR; Cutler JA; Borhani NO; Hennekens CH; Kuller LH; Langford H; Jones DW; Satterfield S; Lasser NL; Cohen JD
    Am J Clin Nutr; 1997 Feb; 65(2 Suppl):652S-660S. PubMed ID: 9022561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Lasser VI; Raczynski JM; Stevens VJ; Mattfeldt-Beman MK; Kumanyika S; Evans M; Danielson E; Dalcin A; Batey DM; Belden LK
    Ann Epidemiol; 1995 Mar; 5(2):156-64. PubMed ID: 7795834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention.
    Whelton PK; Hebert PR; Cutler J; Applegate WB; Eberlein KA; Klag MJ; Keough ME; Hamill S; Borhani NO; Hollis J
    Ann Epidemiol; 1992 May; 2(3):295-310. PubMed ID: 1342280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.
    Stevens VJ; Obarzanek E; Cook NR; Lee IM; Appel LJ; Smith West D; Milas NC; Mattfeldt-Beman M; Belden L; Bragg C; Millstone M; Raczynski J; Brewer A; Singh B; Cohen J;
    Ann Intern Med; 2001 Jan; 134(1):1-11. PubMed ID: 11187414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
    He J; Whelton PK; Appel LJ; Charleston J; Klag MJ
    Hypertension; 2000 Feb; 35(2):544-9. PubMed ID: 10679495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Appel LJ; Hebert PR; Cohen JD; Obarzanek E; Yamamoto M; Buring J; Stevens V; Kirchner K; Borhani NO
    Ann Epidemiol; 1995 Mar; 5(2):149-55. PubMed ID: 7795833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
    Stevens VJ; Corrigan SA; Obarzanek E; Bernauer E; Cook NR; Hebert P; Mattfeldt-Beman M; Oberman A; Sugars C; Dalcin AT
    Arch Intern Med; 1993 Apr; 153(7):849-58. PubMed ID: 8466377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension.
    Geleijnse JM; Witteman JC; Bak AA; den Breeijen JH; Grobbee DE
    BMJ; 1994 Aug; 309(6952):436-40. PubMed ID: 7920126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.
    Hunt SC; Cook NR; Oberman A; Cutler JA; Hennekens CH; Allender PS; Walker WG; Whelton PK; Williams RR
    Hypertension; 1998 Sep; 32(3):393-401. PubMed ID: 9740601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
    Dodson PM; Beevers M; Hallworth R; Webberley MJ; Fletcher RF; Taylor KG
    BMJ; 1989 Jan; 298(6668):227-30. PubMed ID: 2493869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I).
    Batey DM; Kaufmann PG; Raczynski JM; Hollis JF; Murphy JK; Rosner B; Corrigan SA; Rappaport NB; Danielson EM; Lasser NL; Kuhn CM
    Ann Epidemiol; 2000 Jan; 10(1):45-58. PubMed ID: 10658688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group.
    Langford HG; Davis BR; Blaufox D; Oberman A; Wassertheil-Smoller S; Hawkins M; Zimbaldi N
    Hypertension; 1991 Feb; 17(2):210-7. PubMed ID: 1671380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Yamamoto ME; Applegate WB; Klag MJ; Borhani NO; Cohen JD; Kirchner KA; Lakatos E; Sacks FM; Taylor JO; Hennekens CH
    Ann Epidemiol; 1995 Mar; 5(2):96-107. PubMed ID: 7795837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
    Whelton PK; Appel LJ; Espeland MA; Applegate WB; Ettinger WH; Kostis JB; Kumanyika S; Lacy CR; Johnson KC; Folmar S; Cutler JA
    JAMA; 1998 Mar; 279(11):839-46. PubMed ID: 9515998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.